We Know Drug Delivery
on drug delivery logo

e-reader version here -->

Current Issue
(N°82, January 2018)

Ophthalmic Drug Delivery

DOWNLOAD COMPLETE ISSUE: LO RES PDF

DOWNLOAD COMPLETE ISSUE: HI RES PDF

CONTENTS:

Expert View: Sustained Release Ocular Therapeutics
Michael O'Rourke, President and Founder
Scotia Vision Consultants

ARTICLE PDF

Expert View: Using Physical Forces to Enhance Ocular Drug Delivery
Di Huang, PhD Candidate
Erica Chen, Postdoctoral Research Fellow
Ilva D Rupenthal, Senior Lecturer and Director
Buchanan Ocular Therapeutics Unit

ARTICLE PDF

Overcoming the Challenges of Ophthalmic Delivery Using Aqueous-Free Technology: Redefining Dry Eye Disease
Christian Roesky, CEO & Managing Director
Novaliq

ARTICLE PDF

Interview: Fanny Sellier
(Eyedroppers Designed for Patients)

Global Category Manager, Ophthalmic
Nemera

INTERVIEW PDF

Expert View: Establishing Physiocochemical Bioequivalence in Ophthalmic Microemulsions
Paul Kippax, Director, Product Management Morphology
Malvern Panalytical

ARTICLE PDF

Biodegradable Implants for Sustained Intraocular Delivery of Small and Large Molecules
Raj Thakur, CSO, Co-founder
David Jones, CSA, Co-founder
Re-Vana Therapeutics

ARTICLE PDF

Creating Sustainable Biotherapeutics Factories in the Eye to Treat Major Ophthalmic Diseases
Patricia Zilliox, Chief Executive Officer
Eyevensys

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE: LO RES PDF

DOWNLOAD COMPLETE ISSUE: HI RES PDF

Ypsomed


click through to website